Gang Xiao

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 440 citations

Medicine, Oncology, Surgery +17

GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway

Tao Yu, Qi An, Xianglong Cao et al. · Life Sciences · 2020 · 69 citations

Medicine, Oncology, Pharmacology +16

MicroRNA-190 regulates FOXP2 genes in human gastric cancer

Gang Xiao, W.-H. Jia, Tao Yu et al. · OncoTargets and Therapy · 2016 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +15

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2025 · 49 citations

Medicine, Oncology, Surgery +16

Proteomic analysis of differentially expressed proteins between Xiangyou 15 variety and the mutant M15

Zhenqian Zhang, Gang Xiao, Rui-Yang Liu et al. · Frontiers in Biology · 2014 · 46 citations

Life Sciences, Biochemistry, Molecular Biology +13